5-140281512-T-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_002622.5(PFDN1):āc.222A>Cā(p.Glu74Asp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000782 in 1,585,210 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_002622.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PFDN1 | NM_002622.5 | c.222A>C | p.Glu74Asp | missense_variant | 3/4 | ENST00000261813.9 | NP_002613.2 | |
PFDN1 | XM_005268465.5 | c.222A>C | p.Glu74Asp | missense_variant | 3/4 | XP_005268522.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PFDN1 | ENST00000261813.9 | c.222A>C | p.Glu74Asp | missense_variant | 3/4 | 1 | NM_002622.5 | ENSP00000261813.4 |
Frequencies
GnomAD3 genomes AF: 0.000664 AC: 101AN: 152194Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000620 AC: 155AN: 250166Hom.: 0 AF XY: 0.000643 AC XY: 87AN XY: 135280
GnomAD4 exome AF: 0.000795 AC: 1139AN: 1433016Hom.: 0 Cov.: 25 AF XY: 0.000781 AC XY: 558AN XY: 714914
GnomAD4 genome AF: 0.000664 AC: 101AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000592 AC XY: 44AN XY: 74354
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 22, 2021 | The c.222A>C (p.E74D) alteration is located in exon 3 (coding exon 3) of the PFDN1 gene. This alteration results from a A to C substitution at nucleotide position 222, causing the glutamic acid (E) at amino acid position 74 to be replaced by an aspartic acid (D). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at